ARTICLE | Clinical News
Catena idebenone regulatory update
September 7, 2009 7:00 AM UTC
Santhera initiated a European named-patient program to provide access to Catena idebenone for patients with Friedreich's Ataxia (FRDA). The program will be managed by IDIS World Medicines Ltd. (Weybri...